FDA Warns About Johnson & Johnson COVID Vaccine and Guillain-Barré Syndrome Risk—Here's What That Means
FDA Warns About Johnson & Johnson COVID Vaccine and Guillain-Barré Syndrome Risk—Here's What That Means Health.com 2 hrs ago © Provided by Health.com Getty / Photo Illustration by Jo Imperio The US Food and Drug Administration (FDA) has released a new warning that the one-dose Johnson & Johnson (Janssen) COVID-19 vaccine could increase people's risk of developing Guillain-Barré syndrome (GBS), a rare neurological disorder. The FDA added the warning to the vaccine's fact sheet on Monday. The announcement comes after an analysis of the data from the Vaccine Adverse Event Reporting Syst...
Source: msn.com